Sarenthia M. Epps

Researcher

UAMS

Unknown Researcher

4 h-index 8 pubs 43 cited

Research Areas

Biomedical Subjects

OverviewAI-generated summary

Sarenthia M. Epps' research focuses on the intersection of critical care, infectious diseases, and drug-induced pathologies, particularly in the context of severe illnesses like COVID-19. Her work has investigated adverse effects associated with medications used in intensive care settings, such as tocilizumab, and their association with increased risks of fungal infections and acute renal failure. Epps has also examined specific clinical presentations, including a case study of a male patient experiencing lightheadedness and dyspnea, and explored arterial thrombus formation in COVID-19 infections. Her publications include observational cohort studies and case reports, contributing to the understanding of complex patient outcomes in critical care environments. Epps has collaborated with researchers at the University of Arkansas for Medical Sciences, including Nikhil Meena, William T. Atchley, Rajani Jagana, and Barrett J. Burger, on multiple shared publications.

Metrics

h-index: 4
Publications: 8
Citations: 43

Selected Publications

Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study (2023)

Life 9 citations DOI OpenAlex
A 34-Year-Old Man With Lightheadedness and Dyspnea (2022)

CHEST Journal DOI OpenAlex
Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study. (2021)

Research Square 5 citations DOI OpenAlex
Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 (2021)

3 citations DOI OpenAlex
Unprecedented: the toxic synergism of Covid-19 and climate change (2020)

Current Opinion in Pulmonary Medicine 12 citations DOI OpenAlex